Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study
Authors
Keywords
LY2157299, Cardiac safety, Glioma, First-in-human dose study
Journal
Cardiovascular Toxicology
Volume 15, Issue 4, Pages 309-323
Publisher
Springer Nature
Online
2014-12-08
DOI
10.1007/s12012-014-9297-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Shear-Induced Transforming Growth Factor-β Signaling in the Endothelium
- (2013) Tony E. Walshe et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
- (2013) Ivelina Gueorguieva et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study
- (2012) Adedayo A. Onitilo et al. BREAST CANCER RESEARCH AND TREATMENT
- Underestimating Cardiac Toxicity in Cancer Trials: Lessons Learned?
- (2012) Ronald M. Witteles et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Status of Childhood Cancer Survivors Exposed and Unexposed to Cardiotoxic Therapy
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations
- (2012) L. Kristin Newby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease
- (2012) Fabiane L. de Oliveira et al. PLoS Neglected Tropical Diseases
- Transforming growth factor beta signaling in adult cardiovascular diseases and repair
- (2011) Thomas Doetschman et al. CELL AND TISSUE RESEARCH
- Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
- (2011) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
- (2011) Mark J. Anderton et al. TOXICOLOGIC PATHOLOGY
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary
- (2010) et al. CIRCULATION
- Troponin I As a Predictor for Trastuzumab-Related Cardiotoxicity: Current Data Do Not Provide Mechanistic Insights or Allow for Incorporation Into Clinical Practice
- (2010) Shom Goel et al. JOURNAL OF CLINICAL ONCOLOGY
- Signaling via the Tgf-β type I receptor Alk5 in heart development
- (2008) Somyoth Sridurongrit et al. DEVELOPMENTAL BIOLOGY
- Transforming Growth Factor-β Signaling in Thoracic Aortic Aneurysm Development: A Paradox in Pathogenesis
- (2008) Jeffrey A. Jones et al. JOURNAL OF VASCULAR RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started